Qiagen: Instruments for Molecular Diagnostics

QIAGEN is a global biotech company headquartered in Venlo, Netherlands, founded in 1984. With approximately 5,967 employees and operations in over 25 countries, QIAGEN specializes in advanced solutions for the preparation and analysis of biological samples, transforming DNA, RNA, and proteins into valuable molecular information for research, diagnostics, and healthcare.

QIAGEN’s portfolio includes over 500 products, including kits, instruments, and bioinformatics solutions, divided into four main application areas. The molecular diagnostics area covers tests for infectious diseases, oncology, and public health; the academic research area provides solutions for genomics, proteomics, and translational studies; the pharmaceutical industry area offers tools for R&D and biomarker development; and the applied testing area focuses on food safety, forensics, and veterinary applications.

Leasing QIAGEN equipment allows laboratories and biotech organizations to access cutting-edge technologies without a significant upfront investment. This enables them to remain competitive in a constantly evolving sector while benefiting from potential tax advantages through lease payment deductibility.